In vivo spectral and fluorescence microscopy comparison of microvascular function after treatment with OXi4503, Sunitinib and their combination in Caki-2 tumors.
about
In vivo hyperspectral imaging of microvessel response to trastuzumab treatment in breast cancer xenografts.Modulation of the tumor vasculature and oxygenation to improve therapyVascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis.Acute changes in liver tumour perfusion measured non-invasively with arterial spin labelling.The Effect of Sunitinib Treatment in Human Melanoma Xenografts: Associations with Angiogenic Profiles
P2860
In vivo spectral and fluorescence microscopy comparison of microvascular function after treatment with OXi4503, Sunitinib and their combination in Caki-2 tumors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
In vivo spectral and fluoresce ...... combination in Caki-2 tumors.
@ast
In vivo spectral and fluoresce ...... combination in Caki-2 tumors.
@en
type
label
In vivo spectral and fluoresce ...... combination in Caki-2 tumors.
@ast
In vivo spectral and fluoresce ...... combination in Caki-2 tumors.
@en
prefLabel
In vivo spectral and fluoresce ...... combination in Caki-2 tumors.
@ast
In vivo spectral and fluoresce ...... combination in Caki-2 tumors.
@en
P2093
P2860
P356
P1476
In vivo spectral and fluoresce ...... combination in Caki-2 tumors.
@en
P2093
Brian S Sorg
Dietmar W Siemann
Jennifer A Lee
Nikolett M Biel
Raymond T Kozikowski
P2860
P304
P356
10.1364/BOE.5.001965
P577
2014-05-28T00:00:00Z